Marinus Johan, Visser Martine, van Hilten Jacobus Johannes, Lammers Gert Jan, Stiggelbout Anne Margarethe
Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Sleep. 2003 Dec 15;26(8):1049-54. doi: 10.1093/sleep/26.8.1049.
To develop a short and practical scale (SCOPA-SLEEP) that evaluates nighttime sleep and daytime sleepiness. The scale is developed for research in Parkinson disease but may be of value for other somatic diseases.
Postal survey including 4 instruments, the SCOPA-SLEEP nighttime sleep (5 items) and daytime sleepiness (6 items), the Pittsburgh Sleep Quality Index, and the Epworth Sleepiness Scale.
Movement Disorders Center, Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
143 patients with Parkinson disease and 104 controls.
N/A.
Reliability of the scale was high: internal consistency of the nighttime sleep and daytime sleepiness scales were 0.88 and 0.91, respectively (Cronbach alpha), and test-retest reliabilities were 0.94 and 0.89, respectively (intraclass correlation coefficient). Scale scores differed significantly between patients and controls (P < .001). Construct validity was assessed by correlations with scales that addressed similar constructs. Correlation between the nighttime sleep scale and the Pittsburgh Sleep Quality Index was 0.83 (P < .001), and the correlation between the daytime sleepiness scale and the Epworth Sleepiness Scale was 0.81 (P < .001). Factor analysis revealed 1 factor each for both scales, indicating that the scales measure 1 construct, which justifies the calculation of sumscores. The coefficient of variation of both the nighttime sleep and the daytime sleepiness scale was higher than that of the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale, indicating a better ability to detect differences between individuals.
The SCOPA-SLEEP is a reliable and valid instrument for assessing nighttime sleep and daytime sleepiness in patients with Parkinson disease.
开发一种简短实用的量表(SCOPA - 睡眠量表),用于评估夜间睡眠和日间嗜睡情况。该量表专为帕金森病研究而开发,但可能对其他躯体疾病也有价值。
邮寄调查,包括4种工具,即SCOPA - 睡眠量表的夜间睡眠部分(5项)和日间嗜睡部分(6项)、匹兹堡睡眠质量指数以及爱泼华嗜睡量表。
荷兰莱顿大学医学中心神经科运动障碍中心。
143例帕金森病患者和104名对照者。
无。
该量表的信度较高:夜间睡眠量表和日间嗜睡量表的内部一致性分别为0.88和0.91(克朗巴哈α系数),重测信度分别为0.94和0.89(组内相关系数)。患者与对照者的量表得分差异显著(P < 0.001)。通过与涉及相似结构的量表进行相关性分析来评估结构效度。夜间睡眠量表与匹兹堡睡眠质量指数的相关性为0.83(P < 0.001),日间嗜睡量表与爱泼华嗜睡量表的相关性为0.81(P < 0.001)。因子分析显示两个量表各有1个因子,表明这两个量表测量的是1种结构,这为计算总分提供了依据。夜间睡眠量表和日间嗜睡量表的变异系数均高于匹兹堡睡眠质量指数和爱泼华嗜睡量表,表明其检测个体差异的能力更强。
SCOPA - 睡眠量表是评估帕金森病患者夜间睡眠和日间嗜睡情况的可靠且有效的工具。